EXPERIMENTAL STUDIES ON AUXILIARY LIVER TRANSPLANTATION BASED ON REDOX THEORY

基于氧化还原理论的辅助肝移植实验研究

基本信息

  • 批准号:
    05671099
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

1. Establishment of biochemical assays of porcine blood ketone bodies. In this study, it is essential to measure the changes in blood ketone body ratio (acetoacetate/b-hydroxybutyrate, KBR) in both arterial blood of the pigs with failed liver and hepatic vein of the auxiliary transplanted liver. We have found that arterial ketone bodies of th pigs are lower than those of men, rabbits, or rats.2. Partial hepatectomy model as a recipient. Initialy, we have tried to establish a liver failure model in 90% hepatectomized pig. However, a hemodynamically stable model could not be made mainly due to large blood loss. Auxiliary liver transplantation in this model resulted in decrease of KBR in both recipient and auxiliary liver. In this model, we have failed to evaluate the availability of KBR as an index of graft failure.3. Establishment of acute liver failure induced by liver ischemia in pigs with portacaval shunt. Acute liver failure was made by the clamping of the hepatic triads for 6 hours. During liver ischemia, the levels of transaminases, arterial ammonia, and potassium were increased gradually. PT and PTT were prolonged. During the hepatic triads clamping, the arterial ketone bodies were hardly detected. Within 2 hours after the declamping, arterial KBR was recovered temporally, but the ratio continued to decline. All pigs died within 8 hours after the declamping. It was suggested that by measuring the changes in arterial KBR in this model, the efficiency of metabolic support as provided by ex-vivo perfused liver or auxiliary transplanted liver could be assessed.4. Since auxiliary liver transplantation on this animal was found to be possible without large blood loss, we have begun to evaluate the availability of KBR as an index of graft failure in this model.
1. 猪血酮体生化检测方法的建立。在本研究中,有必要测量衰竭肝猪动脉血和辅助肝移植肝静脉血酮体比(乙酰乙酸酯/b-羟基丁酸酯,KBR)的变化。我们发现猪的动脉酮体比人、兔和大鼠的动脉酮体要低。肝部分切除模型作为受体。首先,我们尝试在90%去肝猪身上建立肝衰竭模型。然而,血流动力学稳定的模型无法制作,主要原因是失血过多。本模型辅助肝移植使受体和辅助肝的KBR均降低。在这个模型中,我们没有将KBR的可用性作为移植失败的指标进行评估。门静脉分流术后猪肝缺血致急性肝衰竭的建立。夹紧肝三联管6小时,急性肝功能衰竭。肝缺血时,转氨酶、血氨、血钾水平逐渐升高。PT和PTT均延长。肝三联夹紧时,动脉酮体几乎未检出。去钳后2小时内,动脉KBR暂时恢复,但比率继续下降。所有猪均在取肢后8小时内死亡。我们认为,通过测量该模型中动脉KBR的变化,可以评估离体灌注肝或辅助移植肝提供代谢支持的效率。由于该动物的辅助肝移植可以在不大量失血的情况下进行,我们已经开始评估KBR作为移植失败指标在该模型中的可用性。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A-H.Kwon, S.Uetsuji, O.Yamada, T.Inoue: "Three-dimensional reconstruction of the biliary tract using spiral computed tomography." British Journal of Surgery. 82. 260-263 (1995)
A-H.Kwon、S.Uetsuji、O.Yamada、T.Inoue:“使用螺旋计算机断层扫描对胆道进行三维重建。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A-H,Kwon,Sang Kil Ha-Kawa,S.Uetsuji: "Ues of technetium 99m diethylenetriamine pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy." Surgery. (In
A-H,Kwon,Sang Kil Ha-Kawa,S.Uetsuji:“锝 99m 二亚乙基三胺五乙酸-半乳糖基-人血清白蛋白肝脏显像在评估肝切除术术前和术后肝功能储备中的应用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YOICHI MATSUI: "Effect of hepatocyte volume on energy status in the cirrhotic rat liver" Journal of Gastroernterolgy and Hepatology. 9. 613-619 (1994)
YOICHI MATSUI:“肝细胞体积对肝硬化大鼠肝脏能量状态的影响”胃肠病学和肝脏病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Uetsuji,Y.Okuda,H.Komada Y.Kamiyama: "Gallbladder cancer with double pancreatic ducts-A case report." Hepato-Gastroenterology.41. 497-498 (1994)
S.Uetsuji,Y.Okuda,H.Komada Y.Kamiyama:“双胰管胆囊癌 - 病例报告”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YOICHI MATSUI: "ADENYLATE ENERGY GHARGE OF RAT AND HUMAN CULTURED HEPATOCYTES" In Vitro Cell.Dev.Biol. 30A. 609-614 (1994)
YOICHI MATSUI:“大鼠和人类培养肝细胞的腺苷酸能量”体外 Cell.Dev.Biol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAMIYAMA Yasuo其他文献

KAMIYAMA Yasuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAMIYAMA Yasuo', 18)}}的其他基金

The effect of immunosuppressant FK506 on hepatic function of graft
免疫抑制剂FK506对移植物肝功能的影响
  • 批准号:
    14571243
  • 财政年份:
    2002
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NEW LIVER SUPPORT SYSTEM USING EXVIVO PERFUSED LIVER
使用 EXVIVO 灌注肝脏的新型肝脏支持系统
  • 批准号:
    09671344
  • 财政年份:
    1997
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
  • 批准号:
    10721921
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Paneth cells-derived IL-17A and liver ischemia reperfusion injury
潘氏细胞源性IL-17A与肝脏缺血再灌注损伤
  • 批准号:
    10274320
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
The elucidation of mechanism with propionic acid in liver ischemia and reperfusion injury.
丙酸在肝脏缺血再灌注损伤中的作用机制的阐明。
  • 批准号:
    21K20959
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Paneth cells-derived IL-17A and liver ischemia reperfusion injury
潘氏细胞源性IL-17A与肝脏缺血再灌注损伤
  • 批准号:
    10415225
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
  • 批准号:
    10348751
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
  • 批准号:
    10153767
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
Next generation HDAC inhibitors with superior potency, selectivity, and pharmacokinetic profiles for the treatment of liver ischemia-reperfusion injury
下一代 HDAC 抑制剂具有卓越的效力、选择性和药代动力学特征,用于治疗肝缺血再灌注损伤
  • 批准号:
    9907822
  • 财政年份:
    2019
  • 资助金额:
    $ 1.28万
  • 项目类别:
The elucidation of mechanism of liver ischemia and reperfusion injury by diet restriction
饮食限制导致肝脏缺血再灌注损伤机制的阐明
  • 批准号:
    18K08609
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Innate-Adaptive Immune Interface in Liver Ischemia-Reperfusion Injury
肝脏缺血再灌注损伤中的先天适应性免疫界面
  • 批准号:
    9975698
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
Regulation of Innate Immune Responses by Alloimmunity in Liver Ischemia-Reperfusion Injury
肝脏缺血再灌注损伤中同种免疫对先天免疫反应的调节
  • 批准号:
    9975699
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了